The function of the Epstein-Barr virus nuclear antigen (EBNA) 3 genes will be analyzed. This approach will be a three-fold effort. First, genetic analysis of these genes will be preformed by generating a series of deletional and insertional mutants and assessing the effect of these mutations on the ability of the recombinant viruses to transform primary B lymphocytes as wild-type EBV does. Second, a search for cellular proteins that interact with the EBNA 3 proteins will be undertaken by using the yeast two-hybrid system and fusion-protein pull-down experiments. Once these proteins are identified, the function significance of their interactions with the EBNA 3 proteins will be analyzed by altering the ability of these interactions to occur in the cell and determining the effect on transformation of primary B lymphocytes. Finally, because the EBNA 3 proteins are nuclear proteins and have been shown to interact with RBJk, a cellular DNA binding protein, the induction of cellular genes by these proteins will be studied. To do this, cell lines that express each of the EBNA 3 protein independently will be compared to EBV infected cell lines and noninfected cell lines by differential display analysis. The cDNA's for the cellular genes induced by the EBNA 3 proteins will be cloned and analyzed.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
3F32CA075646-02S1
Application #
6132316
Study Section
Special Emphasis Panel (ZRG5 (01))
Program Officer
Lohrey, Nancy
Project Start
1998-10-01
Project End
Budget Start
1998-10-01
Budget End
2000-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Carter, Kara L; Cahir-McFarland, Ellen; Kieff, Elliott (2002) Epstein-barr virus-induced changes in B-lymphocyte gene expression. J Virol 76:10427-36